Vir Biotechnology, Inc. · NASDAQ:VIR
Vanguard Portfolio Management LLC reported a 5.79% stake in Vir Biotechnology, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Portfolio Management LLC reported a 5.79% stake in Vir Biotechnology, Inc., 9,257,235 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.79%
- Shares
- 9,257,235
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Portfolio Management | 5.79% | 9,257,235 |
Source
Related
- Vir Biotechnology, Inc.
- Vanguard Portfolio Management LLC
- Vir Biotechnology, Inc. shareholders
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · More Robert J · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Coughlin Timothy · Jun 10, 2026
- Form 4 · Napolitano Janet · Jun 2, 2026
- Form 4 · Sabatini Brent · Jun 2, 2026